1 – 36 of 36
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Clonal Hematopoiesis Risk Score and All-Cause and Cardiovascular Mortality in Older Adults
(
- Contribution to journal › Article
-
Mark
Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation
(
- Contribution to journal › Article
-
Mark
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1
2024) In JAMA Cardiology(
- Contribution to journal › Article
-
Mark
Association of Somatic TET2 Mutations With Giant Cell Arteritis
(
- Contribution to journal › Article
-
Mark
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV : a report from the REPRIEVE trial
(
- Contribution to journal › Article
-
Mark
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
(
- Contribution to journal › Article
- 2023
-
Mark
Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood
(
- Contribution to journal › Article
-
Mark
A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets
(
- Contribution to journal › Article
-
Mark
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease
(
- Contribution to journal › Article
-
Mark
Clonal Hematopoiesis and Risk of Incident Lung Cancer
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(7). p.1423-1433(
- Contribution to journal › Article
-
Mark
Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk
(
- Contribution to journal › Article
-
Mark
TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease
(
- Contribution to journal › Article
- 2022
-
Mark
TET2-mutant clonal hematopoiesis and risk of gout
(
- Contribution to journal › Article
-
Mark
Clonal Hematopoiesis Is Associated with Higher Risk of Stroke
(
- Contribution to journal › Article
- 2021
-
Mark
Distinction of lymphoid and myeloid clonal hematopoiesis
(
- Contribution to journal › Article
-
Mark
Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure
(
- Contribution to journal › Article
- 2020
-
Mark
CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia
(
- Contribution to journal › Article
-
Mark
Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemia
(
- Contribution to journal › Article
- 2017
-
Mark
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations
(
- Contribution to journal › Article
-
Mark
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
(
- Contribution to journal › Article
-
Mark
Clonal Hematopoiesis and risk of atherosclerotic cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells
(
- Contribution to journal › Article
- 2016
-
Mark
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML
(
- Contribution to journal › Article
-
Mark
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.
(
- Contribution to journal › Article
- 2015
-
Mark
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
(
- Contribution to journal › Article
- 2014
-
Mark
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS
(
- Contribution to journal › Article
-
Mark
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes.
(
- Contribution to journal › Article
- 2013
-
Mark
InVivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling
(
- Contribution to journal › Article
-
Mark
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells
(
- Contribution to journal › Article
- 2011
-
Mark
Power Cut : Inhibiting Mitochondrial Translation to Target Leukemia
(
- Contribution to journal › Article
-
Mark
Clinical effect of point mutations in myelodysplastic syndromes
(
- Contribution to journal › Article
-
Mark
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice
(
- Contribution to journal › Article
-
Mark
Stem cell gene expression programs influence clinical outcome in human leukemia
(
- Contribution to journal › Article
-
Mark
Densely interconnected transcriptional circuits control cell states in human hematopoiesis
(
- Contribution to journal › Article
- 2009
-
Mark
Ultrasome: efficient aberration caller for copy number studies of ultra-high resolution
(
- Contribution to journal › Article